|
1
|
Lala M, Chirovsky D, Cheng JD and Mayawala
K: Clinical outcomes with therapies for previously treated
recurrent/metastatic head-and-neck squamous cell carcinoma (R/M
HNSCC): A systematic literature review. Oral Oncol. 84:108–120.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinomaan update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sasahira T and Kirita T: Hallmarks of
cancer-related newly prognostic factors of oral squamous cell
carcinoma. Int J Mol Sci. 19:24132018. View Article : Google Scholar :
|
|
4
|
Warnakulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
5
|
Brinton LT, Sloane HS, Kester M and Kelly
KA: Formation and role of exosomes in cancer. Cell Mol Life Sci.
72:659–671. 2015. View Article : Google Scholar
|
|
6
|
Waldenstrom A and Ronquist G: Role of
exosomes in myocardial remodeling. Circ Res. 114:315–324. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Syn N, Wang L, Sethi G, Thiery JP and Goh
BC: Exosome-mediated metastasis: From epithelial-mesenchymal
transition to escape from immunosurveillance. Trends Pharmacol Sci.
37:606–617. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Allenson K, Castillo J, San Lucas FA,
Scelo G, Kim DU, Bernard V, Davis G, Kumar T, Katz M, Overman MJ,
et al: High prevalence of mutant KRAS in circulating
exosome-derived DNA from early-stage pancreatic cancer patients.
Ann Oncol. 28:741–747. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mathieu M, Martin-Jaular L, Lavieu G and
Thery C: Specificities of secretion and uptake of exosomes and
other extracellular vesicles for cell-to-cell communication. Nat
Cell Biol. 21:9–17. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu C, Xu X, Li B, Situ B, Pan W, Hu Y, An
T, Yao S and Zheng L: Single-exosome-counting immunoassays for
cancer diagnostics. Nano Lett. 18:4226–4232. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Chopp M, Meng Y, Katakowski M,
Xin H, Mahmood A and Xiong Y: Effect of exosomes derived from
multipluripotent mesenchymal stromal cells on functional recovery
and neurovascular plasticity in rats after traumatic brain injury.
J Neurosurg. 122:856–867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
van den Boorn JG, Dassler J, Coch C,
Schlee M and Hartmann G: Exosomes as nucleic acid nanocarriers. Adv
Drug Deliv Rev. 65:331–335. 2013. View Article : Google Scholar
|
|
13
|
Fang T, Lv H, Lv G, Li T, Wang C, Han Q,
Yu L, Su B, Guo L, Huang S, et al: Tumor-derived exosomal
miR-1247-3p induces cancer-associated fibroblast activation to
foster lung metastasis of liver cancer. Nat Commun. 9:1912018.
View Article : Google Scholar :
|
|
14
|
Shedden K, Xie XT, Chandaroy P, Chang YT
and Rosania GR: Expulsion of small molecules in vesicles shed by
cancer cells: Association with gene expression and chemosensitivity
profiles. Cancer Res. 63:4331–4337. 2003.PubMed/NCBI
|
|
15
|
Whiteside TL: Exosomes and tumor-mediated
immune suppression. J Clin Invest. 126:1216–1223. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kumar B, Garcia M, Weng L, Jung X,
Murakami JL, Hu X, McDonald T, Lin A, Kumar AR, DiGiusto DL, et al:
Acute myeloid leukemia transforms the bone marrow niche into a
leukemia-permissive microenvironment through exosome secretion.
Leukemia. 32:575–587. 2018. View Article : Google Scholar :
|
|
17
|
Whiteside TL: The effect of tumor-derived
exosomes on immune regulation and cancer immunotherapy. Future
Oncol. 13:2583–2592. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Q, Huang Q, Huyan T, Wang Y, Huang Q
and Shi J: Bifacial effects of engineering tumour cell-derived
exosomes on human natural killer cells. Exp Cell Res. 363:141–150.
2018. View Article : Google Scholar
|
|
19
|
Cai J, Qiao B, Gao N, Lin N and He W: Oral
squamous cell carcinoma-derived exosomes promote M2 subtype
macrophage polarization mediated by exosome-enclosed miR-29a-3p. Am
J Physiol Cell Physiol. 316:C731–C740. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Childs RW and Carlsten M: Therapeutic
approaches to enhance natural killer cell cytotoxicity against
cancer: The force awakens. Nat Rev Drug Discov. 14:487–498. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guillerey C, Huntington ND and Smyth MJ:
Targeting natural killer cells in cancer immunotherapy. Nat
Immunol. 17:1025–1036. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gasser S and Raulet DH: Activation and
self-tolerance of natural killer cells. Immunol Rev. 214:130–142.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raulet DH and Vance RE: Self-tolerance of
natural killer cells. Nat Rev Immunol. 6:520–531. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mamessier E, Sylvain A, Thibult ML,
Houvenaeghel G, Jacquemier J, Castellano R, Goncalves A, Andre P,
Romagne F, Thibault G, et al: Human breast cancer cells enhance
self tolerance by promoting evasion from NK cell antitumor
immunity. J Clin Invest. 121:3609–3622. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pietra G, Manzini C, Rivara S, Vitale M,
Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S,
et al: Melanoma cells inhibit natural killer cell function by
modulating the expression of activating receptors and cytolytic
activity. Cancer Res. 72:1407–1415. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu MC, Xiong P, Li GL and Zhu M: Could
lung cancer exosomes induce apoptosis of natural killer cells
through the p75NTR-proNGF-sortilin axis? Med Hypotheses.
108:151–153. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mincheva-Nilsson L and Baranov V: Cancer
exosomes and NKG2D receptor-ligand interactions: Impairing
NKG2D-mediated cytotoxicity and anti-tumour immune surveillance.
Semin Cancer Biol. 28:24–30. 2014. View Article : Google Scholar
|
|
28
|
Wang Y, Qin X, Zhu X and Chen W, Zhang J
and Chen W: Oral cancer-derived exosomal NAP1 enhances cytotoxicity
of natural killer cells via the IRF-3 pathway. Oral Oncol.
76:34–41. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shoae-Hassani A, Hamidieh AA, Behfar M,
Mohseni R, Mortazavi-Tabatabaei SA and Asgharzadeh S: NK
cell-derived exosomes from NK cells previously exposed to
neuroblastoma cells augment the antitumor activity of
cytokine-activated NK cells. J Immunother. 40:265–276. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Berchem G, Noman MZ, Bosseler M, Paggetti
J, Baconnais S, Le Cam E, Nanbakhsh A, Moussay E, Mami-Chouaib F,
Janji B and Chouaib S: Hypoxic tumor-derived microvesicles
negatively regulate NK cell function by a mechanism involving TGF-β
and miR23a transfer. Oncoimmunology. 5:e10629682015. View Article : Google Scholar
|
|
31
|
Clayton A, Mitchell JP, Court J, Linnane
S, Mason MD and Tabi Z: Human tumor-derived exosomes down-modulate
NKG2D expression. J Immunol. 180:7249–7258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Donatelli SS, Zhou JM, Gilvary DL,
Eksioglu EA, Chen X, Cress WD, Haura EB, Schabath MB, Coppola D,
Wei S and Djeu JY: TGF-β-inducible microRNA-183 silences
tumor-associated natural killer cells. Proc Natl Acad Sci USA.
111:4203–4208. 2014. View Article : Google Scholar
|
|
33
|
Han B, Mao FY, Zhao YL, Lv YP, Teng YS,
Duan M, Chen W, Cheng P, Wang TT, Liang ZY, et al: Altered NKp30,
NKp46, NKG2D, and DNAM-1 expression on circulating NK cells is
associated with tumor progression in human gastric cancer. J
Immunol Res. 2018:62485902018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Viel S, Marçais A, Guimaraes FS, Loftus R,
Rabilloud J, Grau M, Degouve S, Djebali S, Sanlaville A, Charrier
E, et al: TGF-β inhibits the activation and functions of NK cells
by repressing the mTOR pathway. Sci Signal. 9:ra192016. View Article : Google Scholar
|
|
35
|
Contreras-Naranjo JC, Wu HJ and Ugaz VM:
Microfluidics for exosome isolation and analysis: Enabling liquid
biopsy for personalized medicine. Lab Chip. 17:3558–3577. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gonda A, Kabagwira J, Senthil GN and Wall
NR: Internalization of exosomes through receptor-mediated
endocytosis. Mol Cancer Res. 17:337–347. 2019. View Article : Google Scholar
|
|
37
|
Chiossone L, Dumas PY, Vienne M and Vivier
E: Natural killer cells and other innate lymphoid cells in cancer.
Nat Rev Immunol. 18:671–688. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Casu B, Dondero A, Regis S, Caliendo F,
Petretto A, Bartolucci M, Bellora F, Bottino C and Castriconi R:
Novel immunoregulatory functions of IL-18, an accomplice of TGF-β1.
Cancers (Basel). 11:752019. View Article : Google Scholar
|
|
39
|
Rouce RH, Shaim H, Sekine T, Weber G,
Ballard B, Ku S, Barese C, Murali V, Wu MF, Liu H, et al: The
TGF-β/SMAD pathway is an important mechanism for NK cell immune
evasion in childhood B-acute lymphoblastic leukemia. Leukemia.
30:800–811. 2016. View Article : Google Scholar
|
|
40
|
Liénart S, Merceron R, Vanderaa C, Lambert
F, Colau D, Stockis J, van der Woning B, De Haard H, Saunders M,
Coulie PG, et al: Structural basis of latent TGF-β1 presentation
and activation by GARP on human regulatory T cells. Science.
362:952–956. 2018. View Article : Google Scholar
|
|
41
|
Dedobbeleer O, Stockis J, van der Woning
B, Coulie PG and Lucas S: Cutting Edge: Active TGF-β1 released from
GARP/TGF-β1 complexes on the surface of stimulated human B
lymphocytes increases class-switch recombination and production of
IgA. J Immunol. 199:391–396. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fujii R, Jochems C, Tritsch SR, Wong HC,
Schlom J and Hodge JW: An IL-15 superagonist/IL-15Rα fusion complex
protects and rescues NK cell-cytotoxic function from
TGF-β1-mediated immunosuppression. Cancer Immunol Immunother.
67:675–689. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Carnielli CM, Macedo CCS, De Rossi T,
Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle
H, Busso-Lopes AF, et al: Combining discovery and targeted
proteomics reveals a prognostic signature in oral cancer. Nat
Commun. 9:35982018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kourembanas S: Exosomes: Vehicles of
intercellular signaling, biomarkers, and vectors of cell therapy.
Annu Rev Physiol. 77:13–27. 2015. View Article : Google Scholar
|
|
45
|
Filipazzi P, Burdek M, Villa A, Rivoltini
L and Huber V: Recent advances on the role of tumor exosomes in
immunosuppression and disease progression. Semin Cancer Biol.
22:342–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Whiteside TL: Exosome and mesenchymal stem
cell cross-talk in the tumor microenvironment. Semin Immunol.
35:69–79. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Théry C, Ostrowski M and Segura E:
Membrane vesicles as conveyors of immune responses. Nat Rev
Immunol. 9:581–593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Li I and Nabet BY: Exosomes in the tumor
microenvironment as mediators of cancer therapy resistance. Mol
Cancer. 18:322019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kruse PH, Matta J, Ugolini S and Vivier E:
Natural cytotoxicity receptors and their ligands. Immunol Cell
Biol. 92:221–229. 2014. View Article : Google Scholar
|
|
50
|
Lv LH, Wan YL, Lin Y, Zhang W, Yang M, Li
GL, Lin HM, Shang CZ, Chen YJ and Min J: Anticancer drugs cause
release of exosomes with heat shock proteins from human
hepatocellular carcinoma cells that elicit effective natural killer
cell antitumor responses in vitro. J Biol Chem. 287:15874–15885.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Reiners KS, Topolar D, Henke A, Simhadri
VR, Kessler J, Sauer M, Bessler M, Hansen HP, Tawadros S, Herling
M, et al: Soluble ligands for NK cell receptors promote evasion of
chronic lymphocytic leukemia cells from NK cell anti-tumor
activity. Blood. 121:3658–3665. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Reiners KS, Dassler J, Coch C and Pogge
von Strandmann E: Role of exosomes released by dendritic cells
and/or by tumor targets: Regulation of NK cell plasticity. Front
Immunol. 5:912014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Habif G, Crinier A, Andre P, Vivier E and
Narni-Mancinelli E: Targeting natural killer cells in solid tumors.
Cell Mol Immunol. 16:415–422. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen JL, Chang CC, Huang YS, Kuo HY, Chen
TY, Wang CW, Kuo SH and Lin YL: Persistently elevated soluble MHC
class I polypeptide-related sequence A and transforming growth
factor-β1 levels are poor prognostic factors in head and neck
squamous cell carcinoma after definitive chemoradiotherapy. PLoS
One. 13:e02022242018. View Article : Google Scholar
|
|
55
|
Jun E, Song AY, Choi JW, Lee HH, Kim MY,
Ko DH, Kang HJ, Kim SW, Bryceson Y, Kim SC and Kim HS: Progressive
impairment of NK cell cytotoxic degranulation is associated with
TGF-β1 deregulation and disease progression in pancreatic cancer.
Front Immunol. 10:13542019. View Article : Google Scholar
|
|
56
|
Astrom P, Juurikka K, Hadler-Olsen ES,
Svineng G, Cervigne NK, Coletta RD, Risteli J, Kauppila JH, Skarp
S, Kuttner S, et al: The interplay of matrix metalloproteinase-8,
transforming growth factor-β1 and vascular endothelial growth
factor-C cooperatively contributes to the aggressiveness of oral
tongue squamous cell carcinoma. Br J Cancer. 117:1007–1016. 2017.
View Article : Google Scholar
|
|
57
|
Vulpis E, Soriani A, Cerboni C, Santoni A
and Zingoni A: Cancer exosomes as conveyors of stress-induced
molecules: New players in the modulation of NK cell response. Int J
Mol Sci. 20:6112019. View Article : Google Scholar :
|
|
58
|
Klöß S, Chambron N, Gardlowski T, Arseniev
L, Koch J, Esser R, Glienke W, Seitz O and Köhl U: Increased sMICA
and TGFβ1 levels in HNSCC patients impair
NKG2D-dependent functionality of activated NK cells.
Oncoimmunology. 4:e10559932015. View Article : Google Scholar
|
